|
2025-05-15 |
2025-05-13 |
V
Vente
|
Foster Jon M
EVP and COO
Dirigeant
|
15 698
-55.4%
369,32
5 797 661 USD
|
15 698
-55.4%
|
369,32
|
5 797 661 USD
|
|
|
2025-02-18 |
2025-02-14 |
V
Vente
|
Berres Jennifer
SVP & Chief Human Res. Officer
Dirigeant
|
5 378
-25.9%
322,31
1 733 362 USD
|
5 378
-25.9%
|
322,31
|
1 733 362 USD
|
|
|
2025-02-18 |
2025-02-14 |
V
Vente
|
Berres Jennifer
SVP & Chief Human Res. Officer
Dirigeant
|
4 155
-16.7%
322,96
1 341 878 USD
|
4 155
-16.7%
|
322,96
|
1 341 878 USD
|
|
|
2024-11-18 |
2024-11-14 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
1 474
-13.5%
357,99
527 677 USD
|
1 474
-13.5%
|
357,99
|
527 677 USD
|
|
|
2024-11-14 |
2024-11-14 |
V
Vente
|
Akdamar Erol R
Group President
Dirigeant
|
2 900
-29.8%
353,00
1 023 700 USD
|
2 900
-29.8%
|
353,00
|
1 023 700 USD
|
|
|
2024-11-14 |
2024-11-14 |
VP
Vente planifiée
|
Billington Phillip G
SVP-Internal Audit Services
Dirigeant
|
3 897
-6.9%
350,00
1 363 950 USD
|
3 897
-6.9%
|
350,00
|
1 363 950 USD
|
|
|
2024-09-12 |
2024-09-12 |
VP
Vente planifiée
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
8 358
-22.0%
385,42
3 221 340 USD
|
8 358
-22.0%
|
385,42
|
3 221 340 USD
|
|
|
2024-07-31 |
2024-07-31 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
2 987
-24.0%
363,51
1 085 804 USD
|
2 987
-24.0%
|
363,51
|
1 085 804 USD
|
|
|
2024-07-31 |
2024-07-29 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
1 864
-13.0%
359,92
670 891 USD
|
1 864
-13.0%
|
359,92
|
670 891 USD
|
|
|
2024-07-31 |
2024-07-29 |
V
Vente
|
Reiner Deborah M
SVP - Mktg. & Communications
Dirigeant
|
3 314
-48.6%
359,96
1 192 914 USD
|
3 314
-48.6%
|
359,96
|
1 192 914 USD
|
|
|
2024-07-29 |
2024-07-29 |
V
Vente
|
Wyatt Christopher F.
SVP & Controller
Dirigeant
|
4 000
-9.0%
360,20
1 440 782 USD
|
4 000
-9.0%
|
360,20
|
1 440 782 USD
|
|
|
2024-07-29 |
2024-07-25 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
1 857
-9.5%
355,05
659 328 USD
|
1 857
-9.5%
|
355,05
|
659 328 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
3 204
-25.3%
326,30
1 045 465 USD
|
3 204
-25.3%
|
326,30
|
1 045 465 USD
|
|
|
2024-05-17 |
2024-05-15 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
1 863
-8.7%
326,18
607 673 USD
|
1 863
-8.7%
|
326,18
|
607 673 USD
|
|
|
2024-05-13 |
2024-05-09 |
V
Vente
|
Cohen Jeffrey E.
SVP-Government Relations
Dirigeant
|
1 650
-24.1%
313,00
516 450 USD
|
1 650
-24.1%
|
313,00
|
516 450 USD
|
|
|
2024-05-13 |
2024-05-09 |
V
Vente
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
6 311
-17.6%
316,88
1 999 825 USD
|
6 311
-17.6%
|
316,88
|
1 999 825 USD
|
|
|
2024-05-08 |
2024-05-06 |
VP
Vente planifiée
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
1 600
-4.5%
309,00
494 400 USD
|
1 600
-4.5%
|
309,00
|
494 400 USD
|
|
|
2024-05-06 |
2024-05-03 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
890
-4.0%
312,00
277 680 USD
|
890
-4.0%
|
312,00
|
277 680 USD
|
|
|
2024-05-06 |
2024-05-02 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
973
-4.2%
312,00
303 576 USD
|
973
-4.2%
|
312,00
|
303 576 USD
|
|
|
2024-03-20 |
2024-03-20 |
VP
Vente planifiée
|
Wasserman Chad J
SVP and CIO
Dirigeant
|
876
-35.7%
330,25
289 299 USD
|
876
-35.7%
|
330,25
|
289 299 USD
|
|
